TY - JOUR
T1 - Differential effects of gonadotropin-releasing hormone, dopamine and somatostatin and their second messengers on the mRNA levels of gonadotropinIIβ subunit and growth hormone in the teleost fish, tilapia
AU - Melamed, Philippa
AU - Gur, Gal
AU - Elizur, Abigail
AU - Rosenfeld, Hannah
AU - Sivan, Berta
AU - Rentier-Delrue, Françoise
AU - Yaron, Zvi
PY - 1996
Y1 - 1996
N2 - In cultured pituitary cells of tilapia, gonadotropin-releasing hormone (GnRH; IO11M 4-24 h), elevation of cyclic AMP (by 10 μM forskolin or 0.2 mM3-isobutyl-1-methylxanthine: IBMX 0.5-36 h) or activation of protein kinase C (PKC; by 12.5 nM tetradecanoyl phorbol-13-acetate: TPA, 0.5–24 h) all increased gonadotropin (GtH) IIβ steady state mRNA levels by three- to fourfold. The involvement of PKA and PKC in the GnRH stimulatory effect on both GtH release and GtH IIβ mRNA levels was corroborated by use of the PKA andPKC inhibitors, H89 and GF109203X, respectively (100 nM) which attenuated the GnRH effect. Incubation with actinomycin D (8 μM, 4–21 h) after preexposure for 24 h to either forskolin (10 μM) or TPA (12.5 nM), revealed that rates of transcript degradation were slower in forskolin-treated cells (T½ = 14.1 h) than in control or TPA-treated cells (T½ = 8.47 or 8.38 h), suggesting a stabilizing effect on the mRNA. Dopamine (DA; 10 μM, 4–36 h) had no apparent effect onsteady state mRNA levels of GtH Ilβ, but reduced GtH release by as much as 75%. Steady state levels of growth hormone (GH) mRNA were not affected by exposure to GnRH (10 nM, 4–24 h), although GH release was more than doubled. Similarly, activation of PKC (by TPA 12.5 nM, 1.5–36 h), which was shownto be essential for the GnRH-stimulatory effect on GH release, did not alter levels of the GH transcript, but increased GHrelease by more than fivefold. DA (10 μM, 4–24 h) moderately increased GH transcript levels (160%) with similar kinetics but lower potency than direct elevation of cAMP (by 10 μM forskolin or 0.2 mM f IBMX, 0.5-36 h) which increased transcript levels by more than fourfold. The involvement of PKA in the DA effect was confirmed when the PKA inhibitor H89 (100 nM, 15 min prior to DA exposure) attenuated the DA effect on GH mRNA levels. Exposure of cells to actinomycin D (8μM, 2–16 h) after treatment with forskolin (10 μM, 24 h) led to a slower rate of transcript degradation than in control cells (T½ = 6.5 h vs. T½ = 4.36 h), suggesting that cAMPalso elicits a stabilizing effect on GH mRNA. Somatostatin (100 nM, 0.5-36 h) had no clear effect on GH transcript levels, but reduced GH release by as much as 90%. These results suggest that activation of either cAMP-PKA or PKC pathways can, possibly by different mechanisms, stimulate mRNA levels of the GtH IIβ gene, but that only the cAMP-PKA pathway stimulates GH mRNA levels. It would appear therefore that GnRH, although stimulating GH release, does not regulate GH transcription in this fish.
AB - In cultured pituitary cells of tilapia, gonadotropin-releasing hormone (GnRH; IO11M 4-24 h), elevation of cyclic AMP (by 10 μM forskolin or 0.2 mM3-isobutyl-1-methylxanthine: IBMX 0.5-36 h) or activation of protein kinase C (PKC; by 12.5 nM tetradecanoyl phorbol-13-acetate: TPA, 0.5–24 h) all increased gonadotropin (GtH) IIβ steady state mRNA levels by three- to fourfold. The involvement of PKA and PKC in the GnRH stimulatory effect on both GtH release and GtH IIβ mRNA levels was corroborated by use of the PKA andPKC inhibitors, H89 and GF109203X, respectively (100 nM) which attenuated the GnRH effect. Incubation with actinomycin D (8 μM, 4–21 h) after preexposure for 24 h to either forskolin (10 μM) or TPA (12.5 nM), revealed that rates of transcript degradation were slower in forskolin-treated cells (T½ = 14.1 h) than in control or TPA-treated cells (T½ = 8.47 or 8.38 h), suggesting a stabilizing effect on the mRNA. Dopamine (DA; 10 μM, 4–36 h) had no apparent effect onsteady state mRNA levels of GtH Ilβ, but reduced GtH release by as much as 75%. Steady state levels of growth hormone (GH) mRNA were not affected by exposure to GnRH (10 nM, 4–24 h), although GH release was more than doubled. Similarly, activation of PKC (by TPA 12.5 nM, 1.5–36 h), which was shownto be essential for the GnRH-stimulatory effect on GH release, did not alter levels of the GH transcript, but increased GHrelease by more than fivefold. DA (10 μM, 4–24 h) moderately increased GH transcript levels (160%) with similar kinetics but lower potency than direct elevation of cAMP (by 10 μM forskolin or 0.2 mM f IBMX, 0.5-36 h) which increased transcript levels by more than fourfold. The involvement of PKA in the DA effect was confirmed when the PKA inhibitor H89 (100 nM, 15 min prior to DA exposure) attenuated the DA effect on GH mRNA levels. Exposure of cells to actinomycin D (8μM, 2–16 h) after treatment with forskolin (10 μM, 24 h) led to a slower rate of transcript degradation than in control cells (T½ = 6.5 h vs. T½ = 4.36 h), suggesting that cAMPalso elicits a stabilizing effect on GH mRNA. Somatostatin (100 nM, 0.5-36 h) had no clear effect on GH transcript levels, but reduced GH release by as much as 90%. These results suggest that activation of either cAMP-PKA or PKC pathways can, possibly by different mechanisms, stimulate mRNA levels of the GtH IIβ gene, but that only the cAMP-PKA pathway stimulates GH mRNA levels. It would appear therefore that GnRH, although stimulating GH release, does not regulate GH transcription in this fish.
KW - Catecholamines
KW - Cyclic AMP
KW - Fishes
KW - Gonadotropin-releasing hormone
KW - Gonadotropins
KW - Growth hormone
KW - Protein kinases
KW - Somatostatin
UR - http://www.scopus.com/inward/record.url?scp=0029771667&partnerID=8YFLogxK
U2 - 10.1159/000127135
DO - 10.1159/000127135
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8895862
AN - SCOPUS:0029771667
SN - 0028-3835
VL - 64
SP - 320
EP - 328
JO - Neuroendocrinology
JF - Neuroendocrinology
IS - 4
ER -